miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells

Journal of Cellular Physiology

Volumn 230, Issue 4, 2015, Pages 903-910

  Zhang, Kun ^a   Dai, Limeng ^a   Zhang, Bo ^a   Xu, Xueqing ^a   Shi, Jiazhong ^a   Fu, Liyuan ^a   Chen, Xuedan ^a   Li, Juan ^a   Bai, Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE; MICRORNA; MICRORNA 203; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; UNCLASSIFIED DRUG; MIRN203 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ESOPHAGUS CANCER; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UPREGULATION; CELL CYCLE CHECKPOINT; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS;

EID: 84919723660     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24821     Document Type: Article

References (42)

1. Abella V, Valladares M, Rodriguez T, Haz M, Blanco M, Tarrio N, Iglesias P, Aparicio LA, Figueroa A. 2012. miR-203 regulates cell proliferation through its influence on Hakai expression. PLoS ONE 7:e52568.
2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
3. Bell LA, Ryan KM. 2004. Life and death decisions by E2F-1. Cell Death Differ 11:137-142.
4. Bian K, Fan J, Zhang X, Yang XW, Zhu HY, Wang L, Sun JY, Meng YL, Cui PC, Cheng SY, Zhang J, Zhao J, Yang AG, Zhang R. 2012. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett 586:804-809.
5. Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, Huang Y. 2011. MicroRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278:786-792.
6. Boulikas T, Vougiouka M. 2003. Cisplatin and platinum drugs at the molecular level (review). Oncol Rep 10:1663-1682.
7. Bracken AP, Ciro M, Cocito A, Helin K. 2004. E2F target genes: Unraveling the biology. Trends Biochem Sci 29:409-417.
8. Bryksin AV, Matsumura I. 2010. Overlap extension PCR cloning: A simple and reliable way to create recombinant plasmids. Biotechniques 48:463-465.
9. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernandez-Piqueras J, Malumbres M. 2008. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13:496-506.
10. Chen XD, Hu HM, Guan XY, Xiong G, Wang Y, Wang K, Li J, Xu XQ, Yang K, Bai Y. 2012. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int J Cancer 130:1607-1613.
11. Chen J, Tran UM, Rajarajacholan U, Thalappilly S, Riabowol K. 2013. ING1b-inducible microRNA203 inhibits cell proliferation. Br J Cancer 108:1143-1148.
12. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, Xing C, Liu Z. 2010. Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15:63-70.
13. Engelmann D, Putzer BM. 2010. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Drug Resist Update 13:119-131.
14. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. 2010. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31:766-776.
15. Grunberger B, Raderer M, Schmidinger M, Hejna M. 2007. Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res 27:2705-2714.
16. Inoue Y, Kitagawa M, Taya Y. 2007. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 26:2083-2093.
17. Jackson SJ, Zhang Z, Feng D, Flagg M, O'Loughlin E, Wang D, Stokes N, Fuchs E, Yi R. 2013. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development 140:1882-1891.
18. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. 2008. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68:2094-2105.
19. Li JA, Chen YX, Zhao JF, Kong FR, Zhang YD. 2011. MiR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett 304:52-59.
20. Lin WC, Lin FT, Nevins JR. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15:1833-1844.
21. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
22. Marinescu VD, Kohane IS, Riva A. 2005. MAPPER: A search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6:79.
23. McCabe ML, Dlamini Z. 2005. The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5:1113-1130.
24. Noguchi S, Mori T, Otsuka Y, Yamada N, Yasui Y, Iwasaki J, Kumazaki M, Maruo K, Akao Y. 2012. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 in human melanoma cells. J Biol Chem 287:11769-11777.
25. Ofir M, Hacohen D, Ginsberg D. 2011. miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 9:440-447.
26. Osada H, Takahashi T. 2007. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 28:2-12.
27. Polager S, Ginsberg D. 2009. P53 and E2f: Partners in life and death. Nat Rev Cancer 9:738-748.
28. Qu Y, Li WC, Hellem MR, Rostad K, Popa M, McCormack E, Oyan AM, Kalland KH, Ke XS. 2013. miR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. Int J Cancer 133:544-555.
29. Rajewsky N. 2006. microRNA target predictions in animals. Nat Genet 38:S8-S13.
30. Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R. 2011. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 4:1698-1709.
31. Saini S, Majid S, Yamamura S, Tabatabai ZL, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. 2010. Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res 17:5287-5298.
32. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG, Jr. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12:95-106.
33. Sherr CJ, McCormick F. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103-112.
34. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Stahle M, Pivarcsi A. 2007. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis. PLoS ONE 2:e610.
35. Stevens C, La Thangue NB. 2004. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 3:1071-1079.
36. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P. 2007. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282:2135-2143.
37. Virag L, Szabo C. 2002. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429.
38. Woods K, Thomson JM, Hammond SM. 2007. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282:2130-2134.
39. Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M, Yu Q. 2009. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev 23:2388-2393.
40. Yi R, Poy MN, Stoffel M, Fuchs E. 2008. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452:225-229.
41. Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J, Cheng HZ, Huang SD. 2011. MicroRNA-203 inhibits cell proliferation by repressing DeltaNp63 expression in human esophageal squamous cell carcinoma. BMC Cancer 11:57.
42. Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X, Gao Z, Xin J, Zhou S, Zhou Z, Yang Y, Sheng W, Zeng Y. 2013. miR-203 suppresses tumor growth and invasion and down-regulates miR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342:121-129.